Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial.
Kubica J, Adamski P, Ostrowska M, Sikora J, Kubica JM, Sroka WD, Stankowska K, Buszko K, Navarese EP, Jilma B, Siller-Matula JM, Marszałł MP, Rość D, Koziński M. Kubica J, et al. Among authors: buszko k. Eur Heart J. 2016 Jan 14;37(3):245-52. doi: 10.1093/eurheartj/ehv547. Epub 2015 Oct 21. Eur Heart J. 2016. PMID: 26491112 Free PMC article. Clinical Trial.
Crushed sublingual versus oral ticagrelor administration strategies in patients with unstable angina. A pharmacokinetic/pharmacodynamic study.
Niezgoda P, Sikora J, Barańska M, Sikora A, Buszko K, Siemińska E, Marszałł MP, Siller-Matula JM, Jilma B, Alexopoulos D, Fabiszak T, Kubica J. Niezgoda P, et al. Among authors: buszko k. Thromb Haemost. 2017 Apr 3;117(4):718-726. doi: 10.1160/TH16-08-0670. Epub 2017 Feb 16. Thromb Haemost. 2017. PMID: 28203684 Clinical Trial.
Comparison of Ticagrelor Pharmacokinetics and Pharmacodynamics in STEMI and NSTEMI Patients (PINPOINT): protocol for a prospective, observational, single-centre study.
Adamski P, Ostrowska M, Sikora J, Obońska K, Buszko K, Krintus M, Sypniewska G, Marszałł MP, Koziński M, Kubica J. Adamski P, et al. Among authors: buszko k. BMJ Open. 2017 Apr 26;7(4):e013218. doi: 10.1136/bmjopen-2016-013218. BMJ Open. 2017. PMID: 28446521 Free PMC article. Clinical Trial.
Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A prospective, observational, single-centre study.
Adamski P, Sikora J, Laskowska E, Buszko K, Ostrowska M, Umińska JM, Sikora A, Skibińska N, Sobczak P, Adamska U, Rość D, Kubica A, Paciorek P, Marszałł MP, Navarese EP, Gorog DA, Kubica J. Adamski P, et al. Among authors: buszko k. PLoS One. 2017 Oct 12;12(10):e0186013. doi: 10.1371/journal.pone.0186013. eCollection 2017. PLoS One. 2017. PMID: 29023473 Free PMC article.
Metabolism of ticagrelor in patients with acute coronary syndromes.
Adamski P, Buszko K, Sikora J, Niezgoda P, Barańska M, Ostrowska M, Paciorek P, Navarese EP, Gorog DA, Kubica J. Adamski P, et al. Among authors: buszko k. Sci Rep. 2018 Aug 6;8(1):11746. doi: 10.1038/s41598-018-29619-9. Sci Rep. 2018. PMID: 30082687 Free PMC article.
METoclopramide Administration as a Strategy to Overcome MORPHine-ticagrelOr Interaction in PatientS with Unstable Angina PectorIS-The METAMORPHOSIS Trial.
Sikora J, Niezgoda P, Barańska M, Buszko K, Skibińska N, Sroka W, Pstrągowski K, Siller-Matula J, Bernd J, Gorog D, Navarese EP, Marszałł MP, Kubica J. Sikora J, et al. Among authors: buszko k. Thromb Haemost. 2018 Dec;118(12):2126-2133. doi: 10.1055/s-0038-1675605. Epub 2018 Nov 19. Thromb Haemost. 2018. PMID: 30453344 Clinical Trial.
Platelet inhibition with standard vs. lower maintenance dose of ticagrelor early after myocardial infarction (ELECTRA): a randomized, open-label, active-controlled pharmacodynamic and pharmacokinetic study.
Kubica J, Adamski P, Buszko K, Barańska M, Sikora J, Marszałł MP, Sobczak P, Sikora A, Kuliczkowski W, Fabiszak T, Kubica A, Jilma B, Alexopoulos D, Navarese EP. Kubica J, et al. Among authors: buszko k. Eur Heart J Cardiovasc Pharmacother. 2019 Jul 1;5(3):139-148. doi: 10.1093/ehjcvp/pvz004. Eur Heart J Cardiovasc Pharmacother. 2019. PMID: 30689800 Clinical Trial.
43 results